Improved Continuation Rate of Depot-Medroxyprogesterone Acetate in Adolescent Mothers by Omar, Hatim A. et al.
University of Kentucky
UKnowledge
Pediatrics Faculty Publications Pediatrics
4-2002
Improved Continuation Rate of Depot-
Medroxyprogesterone Acetate in Adolescent
Mothers
Hatim A. Omar





Click here to let us know how access to this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/pediatrics_facpub
Part of the Pediatrics Commons
This Article is brought to you for free and open access by the Pediatrics at UKnowledge. It has been accepted for inclusion in Pediatrics Faculty
Publications by an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.
Repository Citation
Omar, Hatim A.; Fowler, Amy; and D'Angelo, Sandy, "Improved Continuation Rate of Depot-Medroxyprogesterone Acetate in
Adolescent Mothers" (2002). Pediatrics Faculty Publications. 84.
https://uknowledge.uky.edu/pediatrics_facpub/84
Improved Continuation Rate of Depot-Medroxyprogesterone Acetate in Adolescent Mothers
Notes/Citation Information
Published in International Journal of Adolescent Medicine and Health, v. 14, no. 2, p. 149-152.
© Freund Publishing House Ltd.
The copyright holder has granted permission for posting the article here.
Digital Object Identifier (DOI)
http://dx.doi.org/10.1515/IJAMH.2002.14.2.149
This article is available at UKnowledge: https://uknowledge.uky.edu/pediatrics_facpub/84
lnt J Moiese Med Health 2002; 14(2): 149·1 52. CFreund Publishing House Ltd. 
Improved continuation rate ofDepot-Medroxyprogesterone 
acetate in adolescent mothers 
IIAtim Omar, MD, Amy Fowler and Sandy D'Angelo, PhD 
s~ction of Adolescent Medicine, Department of Pediatrics, University of Kentucky, 
uxington, United States of America 
Afluract: Poor compliance and high discontinuation rates of Depot-Medroxyprogesterone Acetate 
(DMPA) and other contraceptive methods are major factors in the continuing problem of adolescent 
~pw~cy. In this study we attempted to detennine if providing comprehensive health care for teen 
mothers and their babies would improve continuation rates of DMPA. Patients who started DMPA 
bft"«n 111196 and 111/99 were included. Teen mothers and their babies received all their health care 
in this clinic. supported by State funding. Key clements regarding DMPA in this clinic were 
continuity of care, phone and mail reminders of appointments, free DMPA for patients without 
insurance, counseling at each visit and available evening clinic. In the study period a total of299 (age 
I 3·22 )'CliiS) patients were started on DMPA. Fifty-one percent were white, 47% black and 2% others. 
Si\t)'·three percent were single, 20% married, 3% cohabitating and 14% undetennined (missing data). 
Sc\"Cflty-eight percent had one baby and 22% more than one. A total of 189 patients (63.2%) 
continued to be compliant after one year of use and 101 patients (33.8% of total) continued beyond 
the second year. The most common side effect reported was bleeding or spotting (32%), However 
only se\·en patients (2.3%) discontinued usc because of it. It is concluded that continuity of care 
(same suiT and providers on each visit), regular counseling, flexible hours (evening appointments), 
financial ease (free DMPA and no visit charge for those without insurance), combined Teen·Tot 
health visits and regular reminders of appointments may help improve compliance and continuation 
rales in teen mothers leading to better success in preventing repeat teen pregnancy. 
K'P"f'rrls: Adolescence, adolescent contraception, injectable progesterone, Depot Provera, teenage 
mothers, United States 
C«rnpo11411fU: llatim Omar, MD, Associate Professor, Director of Adolescent Medicine and 
Youna Parent programs, J422, Kentucky Clinic, University of Kentucky, Lexington, KY 40536-0284, 
United States. Tel: 8$9-323-6426 ext. 307, Fax. 859-257·7706, E-mail: haomar2@pop.uky.cdu 
Sdm/1114: January II, 2002. Rn>/s1d: January 18, 2002. Acupted: January 19, 2002. 
1:'\'TRODUCTION 
In a recent prospective study in adult 
•-omen. continuation rates for DMPA were 
ttpor1ed to be 6~'., 6 7%, S 5% and S I "/o at 
3. 6, 9 and 12 months respectively (1). 
Prnious studies shO\\-ed various 12-month 
continuation rates, ranging from 23 to 61% 
{2-6). In adolescenu, DMPA continuation 
nzes are c-.-en IO\\u (7 ,8). Pretreatment 
~ling was found to enhance com· 
plia:nce and improve continuation rates of 
O~WA use (9). Other factors related to the 
providers approach to the patient also 
played a role in continuation of DMPA (1). 
Menstrual changes are usually the most 
common reasons for discontinuation of the 
method (1,9). In this study, we reviewed the 
clinical data in regard to DMPA in our 
Young Parent Program in order to assess 
continuation rates. 
METHODS 
A retrospective review of clinic data in 
regard to DMPA use and continuation was 
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done. Patients started on DMPA on or after 
l/l/1996 were included. Total number of 
patients included in the study was 299. See 
Table 1 for demographics. The Young 
Parents Program Clinic in which these 
patients are enrolled provides comprehen-
sive services that are different from most 
conventional primary care clinics. The 
Young Parents Program Clinic: 
Provides comprehensive care: for both 
teen mother and her baby. This includes 
preventive care, reproductive services, 
mental health and acute care visits. We 
also provide care for siblings of the teen 
as well as family counseling. 
- Continuity of care: patients are seen by 
the same staff and attending physicians 
on each vis it. 
Flexible hours: including evening clinic 
to allow teens to attend school or work 
during the day. 
Financial incentives: patients with no 
insurance are given DMPA free of 
charge and no visit charge is applied if 
they cannot afford it. 
Counseling is provided prior to the start 
of any birth control method and at each 
visit. 
- Telephone and/or mail reminders of 
clinic appointments are routinely utiliz-
ed. 
Table 1. Demographic characteristics of 
patients included in the study. 
Mean Age 17.75 years 
Standard Deviation 1.56 years 
Median 17.94 years 











Continuation· rote . of DMPA after 12 
months was 63.2%. 33.8% of patients were 
still using DMP A at 24 months and 15% 
are still continuing after 36 months. This 
percentage ·rate . at 36 months would 
probably be higher when patients of more 
than 24 and less than 36 months are added. 
Seven percent of patients have completed 
48 months. The most common adverse side 
effect reported was spotting or bleeding, 
which was present in 32% of patients, 
however only seven patients (2.3%) 
patients discontinued use because of it. 
Other· side effects such as headaches, 
mood changes and weight gain were 
reported· in 2%, 4% and 31% respectively, 
but were addressed during each visit and 
counseling and education provided. None 
of the patents discontinued use because of 
these side effects. A desired side effect for 
many patients was amenorrhea, which was 
present in 47% of patients. It was not listed 
as an adverse side effect, since many 
patients considered it a convenience rather 
than an annoyance. 
DISCUSSION 
This study looked at a special group of 
patients in a special setting. The Young 
Parents Program is one of the few programs 
in the country that provides care to the 
mother and baby at the same time. Many 
adolescent mothers are more likely to miss 
an appointment for themselves, but are 
more compliant when it comes to their 
babies. Having simultaneous appointments 
allows these patients to save time and effort 
as well as fmancial savings related to 
transportation expenses and missing work 
or school. 
Another factor that helps compliance is 
the evening clinic, which allows these 
patients to avoid problems with their work 
or school. A significant positive influence 
on the patients is the continuity of care, 
which puts them at ease and makes it easier 
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to ask questions and to call if they have any 
doubts about their birth control or any other 
issue. All visits are physician visits with 
education and counseling provided prior to 
the start on DMPA and on each consecutive 
visit. Counseling usually provides detailed 
and honest information on all possible 
health benefits as well as adverse effects, 
which also helps compliance as in other 
studies (1). Many adolescents, just as 
adults, tend to forget appointments 
especially when they are 2-3 months away. 
In our clinic a dual system of telephone and 
mail reminders is utilized and a simultan-
eous appointment for both mother and baby 
is provided almost always. In addition, our 
patient population can obtain all health care 
needs in the clinic, including mental health 
counseling and treatment allowing even 
more reduction of lost time and effort 
moving from clinic to clinic to obtain 
different services. 
Most adolescent mothers have some 
degree of financial difficulty that interferes 
with their access to health care as well as 
their compliance. In our clinic fmancial 
counseling is also routinely provided to 
help patients utilize available State and 
Federal resources for health insurance and 
when neither is available, visit and 
medication charges are waved. All these 
factors are responsible for the much higher 
rate of compliance noted here compared to 
previous reports ( 1-8). 
It has been reported that menstrual 
disturbances were the main culprits for 
discontinuation of DMPA (1,9). In this 
study, bleeding was responsible for discon-
tinuation in only seven patients (2.3%) that 
had heavy bleeding. Most patients with 
spotting and intermittent bleeding were able 
to continue DMPA use. 
CONCLUSION 
Continuity of care, regular counseling, 
flexible hours, financial incentives, combin-
ed teen-tot visits and regular reminders of 
appointments may help to improve DMP A 
continuation rates in teen mothers which 
leads to reduction in repeat pregnane~. 
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Financial cost of social exclusion: follow up study of antisocial children into 
adulthood 
Objectives: To compare the cumulative costs of public services used through to 
adulthood by individuals with three levels of antisocial behaviour in childhood. 
Design: Costs applied to data of 10 year old children from the inner London 
longitudinal study selectively followed up to adulthood. 
Setting: Inner London borough. 
Participants: 142 individuals divided into three groups in childhood: no problems, 
conduct problems, and conduct disorder. 
Main outcome measures: Costs in 1998 prices for public services (excluding 
private, voluntary agency, indirect, and personal costs) used over and above basic 
universal provision. 
Results: By age 28, costs for individuals with conduct disorder w~re I 0.0 times 
higher than for those with no problems (95% confidence interval of bootstrap ratio 
3.6 to 20.9) and 3.5 times higher than for those with conduct problems (1.7 to 6.2). 
Mean individual total costs were £70 0 I 9 for the conduct disorder group (bootstrap 
mean difference from no problem group £62 898; £22 692 to £117 896) and £24 
324 (£16 707; £6594 to £28 149) for the conduct problem group, compared with 
£7423 for the no problem group. In all groups crime incurred the greatest cost, 
followed by extra educational provision, foster and residential care, and state 
benefits; health costs were smaller. Parental social class had a relatively small effect 
on antisocial behaviour, and although substantial independent contributions came 
from being male, having a low reading age, and attending more than two primary 
schools, conduct disorder still predicted the greatest cost. 
Conclusions: Antisocial behaviour in childhood is a major predictor of how much 
an individual will cost society. The cost is large and falls on many agencies, yet few 
agencies contribute to prevention, which could be cost effective. 
ScottS, Knapp M, Henderson J, Maughan B. BMJ 2001;323:191. 
